VOYXACT® (sibeprenlimab-szsi)
Undisclosed CNS condition
Phase not specified (Data presented)Active
Key Facts
Indication
Undisclosed CNS condition
Phase
Phase not specified (Data presented)
Status
Active
Company
About Otsuka
Otsuka America Pharmaceutical, Inc. is the U.S. pharmaceutical arm of Japan's Otsuka Holdings, operating as a commercial-stage biopharmaceutical company. It has a long-standing legacy in neuroscience with marketed products and is actively expanding its pipeline in nephrology, immunology, and CNS disorders through internal R&D and strategic acquisitions like Transcend Therapeutics. The company is led by a seasoned executive team and leverages the global resources of its parent organization to address significant unmet medical needs.
View full company profile